My watch list
my.bionity.com  
Login  

Systagenix Wound Management Limited - Strategic SWOT Analysis Review

Systagenix Wound Management Limited - Strategic SWOT Analysis Review

Summary

Systagenix Wound Management Limited (Systagenix) is a provider of medical devices and services for the treatment of chronic and surgical wounds and the control of bleeding. The company's key products include, ACTISORBAD, APTIC, PROMOGRAN, PROMOGRAN PRISMA, SILVERCEL, NON-ADHERENT and TIELLE. The Systagenix's products are useful to promote wound healing, maintain moist wound healing environment and control bacteria. It also provides solutions for the treatment of various infected tissue types including Necrotic Tissue, Fibrinous Tissue, Granulation Tissue, Epithelial Tissue, Dry Tissue, Moist Tissue, Wet Tissue and Infected Tissue. The company manufactures its products at its production facility in Gargave, the UK. It markets and sells its products in more than 100 countries throughout the world. The company operates as a subsidiary of Systagenix Wound Management Ltd. Systagenix is headquartered in West Sussex, the UK.

Systagenix Wound Management Limited Key Recent Developments

Jul 26, 2011: Systagenix Appoints Joe Woody To Board
Jun 07, 2011: Systagenix Introduces WOUNDCHEK Brand At EWMA 2011 In Belgium
Jun 06, 2011: Systagenix Appoints Ernest Waaser As New CEO

GlobalData’s Systagenix Wound Management Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Health care / Medical products   Market study
Year:   2012
Publisher:   GlobalData
Price:   125.00€
More about GlobalData
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE